Duloxetine withdrawal syndrome in a newborn

Clinical Pediatrics

Volumn 52, Issue 10, 2013, Pages 976-977

  Abdy, Nicole A ^a   Gerhart, Kimberly ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; LAMOTRIGINE; QUETIAPINE;

ARTICLE; BIPOLAR DISORDER; CASE REPORT; FEMALE; HUMAN; HYPERBILIRUBINEMIA; INFANT; MUSCLE TONE; NEWBORN INTENSIVE CARE; PHOTOTHERAPY; PREGNANCY DIABETES MELLITUS; SMOKING; TACHYPNEA; TREMOR; WITHDRAWAL SYNDROME;

ADULT; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; THIOPHENES;

EID: 84884192601     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922812450509     Document Type: Article

References (10)

1. Ferreira E, Carceller AM, Agogué C, et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics. 2007 ; 119: 52-59
2. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005 ; 293: 2372-2383
3. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006 ; 160: 173-176
4. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005 ; 365: 482-487
5. Bot P, Semmekrot BA, van der Stappen J. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy. Arch Dis Child Fetal Neonatal Ed. 2006 ; 91: F153
6. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry. 2004 ; 65: 230-237
7. Warburton W, Hertzman C, Oberlander TF. A register study of the impact of stopping third trimester serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand. 2010 ; 121: 471-479
8. Eyal R, Yaeger D. Poor neonatal adaptation after in utero exposure to duloxetine. Am J Psychiatry. 2008 ; 165: 651
9. Cabuk D, Sayin A, Derinöz O, Biri A. Quetiapine use for the treatment of manic episode during pregnancy. Arch Womens Ment Health. 2007 ; 10: 235-236
10. Harden CL, Meador KJ, Pennell PB, et al. Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009 ; 50: 1237-1246